Kamunting Street Capital Management, L.P. Vbi Vaccines Inc Transaction History

Kamunting Street Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$0.73 - $1.91 $58,400 - $152,800	-80,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.75 - $3.85 $84,403 - $118,164	30,692 Added 62.25%	80,000 $220,000
Q4 2017 Feb 14, 2018	BUY	$3.29 - $5.03 $63,523 - $97,119	19,308 Added 64.36%	49,308 $211,000
Q3 2017 Nov 14, 2017	BUY	$3.15 - $4.01 $94,500 - $120,300	30,000	30,000 $116,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.